Galectin Therapeutics Late-Breaker Presentation at The International Liver Congress Reinforces and Extends the Positive Effects of GR-MD-02 in Patients With NASH Cirrhosis


You May Also Like

OPKO Health Reports Second Quarter 2018 Financial Results

Conference Call begins today at 4:30 p.m. Eastern TimeMIAMI, Aug. 07, 2018 (GLOBE NEWSWIRE) ...

AstraZeneca completes agreement with LEO Pharma

This announcement contains inside information 16 August 2016 07:00 ASTRAZENECA COMPLETES GLOBAL LICENCING AGREEMENT ...